These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure. Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440 [TBL] [Abstract][Full Text] [Related]
3. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112 [TBL] [Abstract][Full Text] [Related]
4. Intravenous use of amrinone for the treatment of the failing heart. Mancini D; LeJemtel T; Sonnenblick E Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122 [TBL] [Abstract][Full Text] [Related]
5. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure. Packer M; Medina N; Yushak M Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324 [TBL] [Abstract][Full Text] [Related]
6. Amrinone in the management of low cardiac output after open heart surgery. Goenen M; Pedemonte O; Baele P; Col J Am J Cardiol; 1985 Jul; 56(3):33B-38B. PubMed ID: 4025158 [TBL] [Abstract][Full Text] [Related]
7. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure. Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure. Siegel LA; Keung E; Siskind SJ; Forman R; Feinberg H; Strom J; Efstathakis D; Sonnenblick EH; LeJemtel TH Circulation; 1981 Apr; 63(4):838-44. PubMed ID: 7471340 [No Abstract] [Full Text] [Related]
9. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure. Packer M; Medina N; Yushak M Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545 [TBL] [Abstract][Full Text] [Related]
10. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184 [TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic effects of amrinone, dobutamine and dopamine in the cardiac low output syndrome following open-heart surgery]. Husedzinović I; Rumboldt Z; Ivancan V; Nikić N; Rudeź I; Biocina B; Sutlić Z Lijec Vjesn; 1995 Jun; 117 Suppl 2():32-4. PubMed ID: 8649147 [TBL] [Abstract][Full Text] [Related]
12. Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone. Guimond JG; Matuschak GM; Meyers F; Keating D Chest; 1986 Aug; 90(2):302-4. PubMed ID: 3731911 [TBL] [Abstract][Full Text] [Related]
13. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Loeb HS; Bredakis J; Gunner RM Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine. Boncyk J; Redon D; Rusy B Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):347-54. PubMed ID: 6463363 [TBL] [Abstract][Full Text] [Related]
15. [Dopamine and dobutamine in the treatment of severe cardiac failure (author's transl)]. Wirtzfeld A; Klein G; Delius W; Himmler C; Volger E; Davidson J Dtsch Med Wochenschr; 1978 Dec; 103(48):1915-21. PubMed ID: 710319 [TBL] [Abstract][Full Text] [Related]
16. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Benotti JR; Grossman W; Braunwald E; Carabello BA Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283 [TBL] [Abstract][Full Text] [Related]
17. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation]. De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199 [TBL] [Abstract][Full Text] [Related]
18. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Leier CV; Heban PT; Huss P; Bush CA; Lewis RP Circulation; 1978 Sep; 58(3 Pt 1):466-75. PubMed ID: 679437 [TBL] [Abstract][Full Text] [Related]
19. Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction. Taylor SH; Verma SP; Hussain M; Reynolds G; Jackson NC; Hafizullah M; Richmond A; Silke B Am J Cardiol; 1985 Jul; 56(3):29B-32B. PubMed ID: 4025156 [TBL] [Abstract][Full Text] [Related]